The Tamiflu story: Why we need access to all data from clinical trials
The BMJ Open Data Campaign has been attracting a lot of attention. Here Dr Tom Jefferson, one of the people whose attempts to provide reliable information on the anti-flu drug…
Tom Jefferson
Dr Tom Jefferson is one of the editors of the Cochrane Acute Respiratory Infections (ARI) Group, and a member of six other Cochrane review groups. His main research interests are the application of systematic reviewing methods to studies of antivirals and vaccines of different designs (such as trials, economic evaluations and epidemiological studies) and editorial peer review.